scholarly journals The Calcium/Phosphorus Homeostasis in Chronic Kidney Disease: From Clinical Epidemiology to Pathophysiology

2017 ◽  
Vol 30 (6) ◽  
pp. 485 ◽  
Author(s):  
Ana Pires ◽  
Luis Sobrinho ◽  
Hugo Gil Ferreira

Introduction: A simple data filtering process together with some basic concepts of control theory applied to electronically stored clinical data were used to identify some of the pathophysiological mechanisms underlying the perturbations of the calcium/phosphorus homeostasis in chronic kidney disease.Material and Methods: Retrospective data (a set per patient of serum single value concentrations of creatinine, calcium, phosphorus, parathormone, 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D) from 2507 patients with stable chronic kidney disease not on renal replacement therapy were studied. The variables were paired and subjected sequentially to a moving average and partioned into frequency classes. The plots were interpreted using the concept of a feedback loop comprising two branches of opposite sign and of set point of the loop. The set point for each pair of variables is displaced in the course of the disease and this displacement indicates which of the two factors involved (the serum concentrations of calcium or parathormone, for example) is primarily affected.Results: This analysis showed that in the course of the development of chronic kidney disease the relationships between the observed variables progressed following a monotonous, a biphasic or a triphasic pattern.Discussion: As chronic kidney disease progresses, calcium/phosphorus metabolism regulation evolves through different phases. Later, there is a progressive loss of the parathyroid gland sensitivity to the control by the serum concentrations of calcium and phosphorus. The sensitivity to the inhibitory action of 1,25-dihydroxyvitamin D decreases monotonously but never releases the gland.Conclusion: The clinical data analysis used permits to illustrate the underlying pathophysiological mechanisms.

2008 ◽  
Vol 12 (2) ◽  
pp. 126-131 ◽  
Author(s):  
Daijo Inaguma ◽  
Hiroshi Nagaya ◽  
Kazuhiro Hara ◽  
Miho Tatematsu ◽  
Hibiki Shinjo ◽  
...  

2016 ◽  
Vol 86 (11) ◽  
pp. 229-235 ◽  
Author(s):  
Daijo Inaguma ◽  
Hibiki Shinjo ◽  
Akihito Tanaka ◽  
Eri Ito ◽  
Naoki Kamegai ◽  
...  

2021 ◽  
Vol 17 (5) ◽  
pp. 385-392
Author(s):  
N.V. Karlovich ◽  
T.V. Mokhort

Background. Secondary hyperparathyroidism (SHPT) is universal complication of chronic kidney disease (CKD), the likelihood of which increases as renal function decreases. Currently, SHPT is considered in the context of mineral and bone disorders associated with CKD. Mineral and bone disorders associated with CKD include, in addition to SHPT, disorders of calcium-phosphorus metabolism, bone pathology and metastatic calcification, which determine poor outcomes of the disease. The purpose of the study was to evaluate the serum concentrations of fibroblast growth factor (FGF) 23 and Klotho protein in patients with various stages of CKD and their relationship with SHPT, vitamin D levels, and calcium-phosphorus metabolism in patients with varying degrees of decreased renal function. Materials and methods. Serum concentrations of FGF 23, Klotho protein, parathyroid hormone (PTH), 25(OH)D, calcium and phosphorus were evaluated in 229 patients with various stages of chronic kidney disease and in 40 people without signs of CKD. Results. It has been shown that individuals with CKD are characterized by overproduction of humoral phosphatonin FGF 23 and Klotho deficiency, which increase as renal failure worsens. A significant relationship was established between FGF 23 and the levels of PTH and blood phosphorus; Klotho protein — with the patient’s age and serum vitamin D. An early marker of disorders in the FGF 23-Klotho system is a decrease in the Klotho protein concentration, which occurs in the early stages of CKD and is aggravated with the progression of renal failure. A statistically significant overproduction of FGF 23 associated with secondary hyperparathyroidism was registered in patients with glomerular filtration rate less than 35 ml/min/1.73 m2. Conclusions. An early marker of disorders in the FGF 23-Klotho system is a decrease in the concentration of the Klotho protein, which occurs in the early stages of CKD and is aggravated with the progression of renal fai-lure. The relationship between Klotho deficiency and the formation of SHPT has not been found. As kidney function decreases, excess production of PTH and FGF 23 appears and increases, hyperphosphatemia progresses. This proves the pathogenetic relationship between the formation of SHPT and the overproduction of humoral phosphatonin FGF 23, since it is this glomerular filtration rate that determines the growth of PTH above the upper limit of the general population reference interval.


2015 ◽  
Vol 28 (6) ◽  
pp. 564-577 ◽  
Author(s):  
Arnold J. Felsenfeld ◽  
Barton S. Levine ◽  
Mariano Rodriguez

2018 ◽  
Vol 33 (2) ◽  
pp. 662-669 ◽  
Author(s):  
Stacie C. Summers ◽  
Jessica M. Quimby ◽  
Anitha Isaiah ◽  
Jan S. Suchodolski ◽  
Paul J. Lunghofer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document